SCHEMBL17702102

SCHEMBL17702102

Cc1ccc(N(c2ccc(C)cc2)c2ccc(N(c3ccc(N(c4ccc5ccccc5c4)c4ccc5c(ccc6ccccc65)c4)cc3)c3ccc(N(c4ccc5ccccc5c4)c4ccc5c(ccc6ccccc65)c4)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2A6 P11509 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP1B1 Q16678 2/20 0.44
HIF1A Q16665 1/20 0.44
CYP1A2 P05177 7/20 0.42
HPGD P15428 3/20 0.42
HPRT1 P00492 3/20 0.42
TSHR P16473 2/20 0.40
CYP1A1 P04798 1/20 0.40
MAPT P10636 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MAOA P21397 2/20 0.39
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13241927 0.97 ALDH1A1 (0.47) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL17702093 0.90 HPRT1 (0.44) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL13432540 0.90 CYP2A6 (0.61) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL20466435 0.89 ALDH1A1 (0.54) CYP2A6TDP1ALDH1A1HSD17B10CYP1B1
SCHEMBL17930284 0.89 ALDH1A1 (0.54) CYP2A6TDP1ALDH1A1HSD17B10CYP1B1
SCHEMBL12744246 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL10053532 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL12111309 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL18134989 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL15306101 0.89 HTT (0.47) HTTNPSR1L3MBTL1CYP2A6TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9755165-B2 Silsesquioxane compound, organic light emitting element, display apparatus, image information processing apparatus, and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2017-09-05 US disclosed
US-20160118607-A1 SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118607-A1 SILSESQUIOXANE COMPOUND, ORGANIC LIGHT EMITTING ELEMENT, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, AND IMAGE FORMING APPARATUS SFXN1, LSS, SLC7A5 HTT 2934/4885NPSR1 2269/4885L3MBTL1 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.